Accustem Sciences INC 8-K filings
Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.
OQB
AccuStem Sciences Inc.'s MSC test, a non-invasive blood-based assay for lung cancer risk, has advanced to the review queue for Medicare reimbursement with Novitas Solutions.
OQB
AccuStem Sciences Inc. has appointed Mercurius & Associates LLP as its new independent registered public accounting firm, replacing the previous auditor.
OQB
AccuStem Sciences Inc. has appointed Mercurius LLP as its new independent registered public accounting firm, effective June 17, 2024.
OQB
AccuStem Sciences Inc. has announced that its independent auditor, Mazars USA LLP, will resign effective upon the filing of the company's Form 10-Q for the quarter ended March 31, 2024.